Two-Part Hematoxylin Formulation for Precipitate-Free Automated Staining
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Hematoxylin staining solutions used in automated systems often form precipitates, leading to clogging and staining inconsistencies due to the formation of hematein-mordant complexes, which affect diagnostic utility and require frequent module replacements.
Innovation Solution
A two-part hematoxylin stain composition is formulated at a low pH (less than 2.4) to stabilize the solution, preventing substantial precipitation, and a readjustment solution is used to raise the pH to a suitable staining level (2.45-2.6) just before use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Extent of automation
If hematoxylin staining solution is used in automated systems, then staining can be performed automatically, but precipitates form causing clogging and staining inconsistencies
Solution Approach 1:
The hematoxylin staining system is divided into two separate components: a stabilized hematoxylin formulation (pH < 2.4) and a readjustment solution. This segmentation prevents precipitate formation in the stored formulation while allowing pH adjustment at the point of use to achieve consistent staining results in automated systems.
Solution Approach 2:
The pH parameter of the hematoxylin formulation is changed to a highly acidic range (pH < 2.4) to stabilize the solution and prevent precipitate formation. The readjustment solution then raises the pH to the optimal staining range (pH 2.45-2.6) just before use, resolving the contradiction between stability and staining performance.
2Duration of action of stationary object
If hematoxylin solution is stored for extended periods, then reagent availability is improved, but precipitates form leading to clogging
Solution Approach 1:
The pH parameter is changed to a highly acidic range (pH < 2.4) to stabilize the hematoxylin formulation during storage. This parameter change prevents precipitate formation and allows extended storage without clogging, while the readjustment solution restores the optimal pH for staining at the point of use.
Solution Approach 2:
The hematoxylin formulation is pre-stabilized at low pH before storage to prevent precipitate formation. The pH readjustment is performed as a preliminary action just before use, allowing the system to maintain stability during storage while achieving optimal staining performance when needed.
3Stability of the object's composition
If pH is raised to stabilize hematoxylin solution, then precipitate formation is prevented, but staining effectiveness is reduced
Solution Approach 1:
The system separates the stabilization function (low pH formulation) from the staining function (pH-adjusted solution). The stabilized hematoxylin formulation maintains composition stability at pH < 2.4, while the readjustment solution provides the necessary pH increase to pH 2.45-2.6 for effective staining, resolving the contradiction between stability and staining accuracy.
Solution Approach 2:
The pH adjustment is performed as a preliminary action just before staining, allowing the formulation to remain stable during storage while achieving optimal staining conditions at the point of use. This timing separates the stability requirement from the staining effectiveness requirement.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The stabilized hematoxylin formulation remains precipitate-free for extended periods, ensuring consistent staining results and reducing maintenance issues in automated systems by preventing clogging and maintaining diagnostic accuracy.
Implementation Method 1
reducing the pH of a starting hematoxylin staining composition to a pH of less than 2.4, wherein the pH is reduced by adding an acid to the hematoxylin staining composition
Implementation Method 2
compositions comprising hematoxylin and hematein are commonly used in pathology and histology
Data Source
AI summary
The present disclosure provides stabilized hematoxylin formulations having a pH of less than 2.4. In general, the stabilized hematoxylin formulations comprise a solvent, a hematoxylin dye, and an acid. The present disclosure also provides methods of using such stabilized hematoxylin formulations to stain biological samples. The present disclosure also provides for methods of readjusting the pH of a stabilized hematoxylin formulation to provide a hematoxylin staining solution.